Australia Curbs GMP Inspections As Coronavirus Bites
Regulator Also Updates On Shortage And Vaccine Actions
Executive Summary
The Australian drugs and devices regulator says that international travel curbs relating to the COVID-19 outbreak have forced it to cut back on its inspections of overseas drug manufacturers. It is also looking out for potential drug shortages and will give the “highest priority” to any new drugs and vaccines that are developed for the virus.